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Oral manifestations in HIV+ children in Mozambique
Manifestações orais em crianças HIV, em Moçambique
Resumo  O objetivo deste estudo foi identificar a
prevalência das manifestações bucais em pacien-
tes HIV+/SIDA do Hospital Pediátrico DIA de
Maputo. Foram incluídos 90 pacientes na pes-
quisa. Cárie dentária (índice ceod/CPOD), mu-
cosa e fluxo salivar foram avaliados. Informações
sobre alimentação e hábitos de higiene bucal fo-
ram obtidas por meio de um questionário. Para a
análise estatística foram utilizados os testes t-stu-
dent e qui-quadrado. A lesão oral mais frequente
foi a candidíase (5,5%) e no exame extra-oral foi
observada uma prevalência de alargamento da pa-
rótida de 23%. A média do ceod foi 2,6 (± 3,6)
dentes, consideravelmente alta em relação ao
CPOD que foi de 0,6 (±1,6) dentes, sendo esta
diferença estatisticamente significante (p<0,05).
A ocorrência de lesões na mucosa bucal foi maior
em crianças que não faziam uso da terapia anti-
retroviral (TRA). O uso da TRA esteve associado
com a redução da prevalência de lesões bucais em
pacientes HIV+, contudo cáries rampantes foram
maiores neste grupo.  Pacientes HIV+ mostraram
maior risco de cáries na dentadura decídua.
Palavras-chave  Moçambique, Manifestações
bucais, Infecções por HIV, Pediatria
Abstract  The scope of this study was to identify
the prevalence of oral manifestations in HIV+/
AIDS patients at the DIA Pediatric Hospital of
Maputo. All 90 patients were included in the re-
search. Data on dental caries (dmft/DMFT in-
dex), soft tissues and saliva flow were analyzed.
Information on diet and hygienic habits was ob-
tained in a semi-structured questionnaire. The
t- student and chi-square tests were used for sta-
tistical assessment.  The most frequent oral lesion
was candidiasis (5.5%) and upon further oral
examination the prevalence of parotid enlarge-
ment was 23.0%. The mean dmft 2.6 (SD 3.6)
was considerably higher in relation to DMFT of
0.6 (SD 1.6), and the differences between them
were statistically significant (P<0.05). The oc-
currence of mucosal lesions was higher in chil-
dren who did not take antiretroviral therapy
(ART) (p= 0.026). The use of ART is associated
with reduced prevalence of oral lesions in HIV+
patients; however, rampant caries were highest
in this group. Primary dentition of HIV+ pa-
tients should be considered high risk for caries.
Key words  Mozambique, Oral manifestations,
HIV infections, Pediatrics
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Introduction
In worldwide it is estimated that there are 2.3
million HIV positive children from 0 to 14 years
infected by mothers1. Many of those infected chil-
dren were born in the 1980s, today, are with the
disease under control, when before the expectan-
cy life was 4 years old, nowadays this number
has increased to 20 years old2,3.
In Mozambique, AIDS is emerging rapidly
affecting infant mortality. In 2006, about 99,000
children under the age of 15 were living with HIV
or AIDS, the majority were below the age of five.
Most children have been infected through moth-
er-to-child transmission of HIV and many do
not live for long without treatment 4.
Oral lesions indicate infections with human
immunodeficiency virus (HIV). They are among
the early clinical features of the infection and can
predict progression of HIV disease to acquired
immunodeficiency syndrome (AIDS). The pres-
ence and development of oral lesions are used as
criteria for prophylaxis and therapy 5,6.
Oral health is considered integral and insep-
arable part of the general health of the individu-
al. The absence of a healthy oral cavity can affect
the quality of life, complicating the treatment of
medical conditions and create or exacerbate psy-
chosocial and nutritional problems7. In children,
the quality of life related to health should be con-
sidered differently from adults. The high preva-
lence of HIV infection reinforces the need of den-
tists and his staff to update the prevention and
treatment of diseases and the promotion and
maintenance oral health of individuals with HIV
/ AIDS. These children are susceptible to infec-
tion by many microrganisms that have prolifer-
ated under conditions of immunosuppressive,
causing injuries fungal, viral and bacterial, such
as candidiasis, linear gingival erythema, herpes,
and hypertrophy of parotid, among others8.
Although the use of active retroviral therapy
(ART) in HIV-infected children is promoting a
reduction in the prevalence of oral manifestations
over the years, there is an increase in the high prev-
alence of dental diseases, mainly due to the chronic
influence of some factors involved in the process
of HIV infection. Among them are the prolonged
use of sugary products, changes in salivary flow
and salivary glands caused by use of drugs, diet
rich in carbohydrates to protein-calorie replace-
ment, repeated episodes of hospitalization, poor
oral hygiene, immunosuppression by infection of
HIV and the lack of information about the prac-
tice of promoting oral health3,9,10.
The prevention of oral infections and early
diagnosis associated with oral manifestations
increase the life expectancy and well being of the
patient. However, it is still significant the number
of children who live with the symptoms of the
disease, making it essential and urgent to search
for tools to improve oral health of children, since
the prevalence of oral manifestations is very high.
This study aims to evaluate oral manifestations
of HIV-infected children in ambulatory of pae-
diatric DAY of Maputo Hospital, Mozambique.
Materials and Methods
Ethical aspects
This project was approved by Maputo Cen-
tral Hospital / Ministry of Health of Mozambique.
Written consent for participation in the study was
obtained from children’s parents/caregivers.
Sample
Ninety children diagnosed HIV-infected, at-
tending the pediatric DAY Hospital, an unit of
Maputo Central Hospital in Mozambique. Their
HIV and medication status were confirmed
through the patients file. The sample aged be-
tween 1.7 and 16 years old (mean 6,57).
Approximately 10% of the sample was re-ex-
amined in order to verify the intra-examiner re-
producibility. Intra-examiner agreement was 0.84
(88.89%) expressed by the Kappa statistics. This
value indicated reliability within almost perfect11.
Examination methodology
One previously calibrated examiner outdoors
performed clinical examination, under natural
light, using CPI probes (“ball point”), mirrors
#5, according to the WHO Basic methods. Den-
tal caries were registered using the dmft (total of
decayed, missing, and filled primary teeth) and
DMFT (total of decayed, missing, and filled per-
manent teeth) indexes12.
Examination of the soft tissues of the face
was based on inspection, palpation of the parot-
id region. To evaluate intra-oral tissues was used
wooden spatula. Ramos-Gomez et al.13, whom
proposed a classification of oral-facial lesions
associated with paediatric AIDS, recommended
the use of this criterion.
The salivary flow was obtained in children
above 6 years old (n=59). To collect saliva, they
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were instructed to chew rubber during five min-
utes while they were expectorating into the cup.
Later the researcher made the suction of the sali-
va and measured in millilitres using graduated
syringe. Values below 1ml/min are considered low
salivary flow14. For the parents/caregivers were
applied semi-structured questionnaire address-
ing diet and hygienic habits.
Data Analyses
The descriptive and analytical approaches
were used for data analysis. Descriptive results
were analyzed as relative frequencies.  Data were
processed and analysed using Statistical packag-
es STATISTICA 7.0.  The t-student and chi-square
tests were used for Statistical assessment. Odds
Ratio was used to estimated influence of salivary
flow and the use of ART in occurrence of lesions
in the oral mucosa, parotid hypertrophy and
dental caries. The data were analyzed using 5%
significance level.
Results
The sample comprised a total of 90 patients, be-
ing boys (n=44; 48.8%) and girls (n=46; 51.0%).
Almost patients were taking active retroviral ther-
apy (81.0%), only 18.8% were not in ART.
The salivary flow was evaluated in 59 chil-
dren, where the low salivary flow was found in
76.2%. The parotid enlargement was the second
manifestation (23%).
The analyses also showed no significance
(p>0.050) between flow salivation and parotid
hypertrophy, oral lesions in mucosal and dental
caries (Table 1).
The total of mucosal lesions was about 12
cases (13.3%) distributed among 7 patients. The
most common was angular queilitis (a type of
candidiasis) that was present in 4% of patients.
The distribution of mucosal lesion’s was: angu-
lar chelitis, gingivitis,   herpetic stomatit, herpetic
stomatit + angular chelitis, pseudomembrane-
ous candidiasis + angular chelitis + gingivitis; fis-
tula and herpetic labials.
The “t” Student test showed statistically dif-
ference between use of ART and oral lesions in
mucosal, showing that the mean of lesions was
higher than those did not use of ART (p= 0.026).
When the variable “lesions” was categorized as
presence and absence of oral lesion (Table 2) for
calculate the chi-square test, was found no asso-
ciation (p=0.472). The ART’s users presented oral
lesion was small (n=7). However, the Odds Ra-
tio showed those patients who make use of ART
have 2.39 times less likely to have lesions in the
oral mucosa.
The Odds Ratio analyses showed no statisti-
cal significant (p=0.328) between use of ART and
parotid hypertrophy.
The mean of dmft was 2.6 while the DMFT
score showed 0.6. Most of all dental caries were
rampant, especially in primary dentition. “t” Stu-
dent analyses the comparison between those who
taking ART and dmft/DMFT showed no signifi-
cance (p=0.798 / p=0.090), but when the variable
dmft/DMFT was categorized into presence and
absence of caries observed association between
dental caries and the use of ART (p <0.000). The
table 2 shows the distribution of mucosal lesion,
hypertrophy of parotid gland and dental caries
according to use of antiretroviral therapy (ART).
Almost of used fluoride paste (95%), and
only (1.1%) use dental floss. Half of the patients
Total
Mucosal Lesion
Presence
Absent
Parotid Gland
Hipertrophy
Normal
Dental caries
dmft=0
dmft>0
DMFT=0
DMFT>0
Low salivary flow
n (%)
45 (76.3)
4 (8.9)
41 (91.1)
9 (20.0)
36 (80.0)
14 (31.1)
31 (68.9)
32 (71.1)
13 (28.9)
n (%)
14 (23.7)
3 (21.4)
11 (78.6)
4 (28.6)
10 (71.4)
3 (21.4)
11 (78.6)
8 (57.1)
6 (42.9)
OR (IC=95%)
0.36 (0.07 – 1.84)
0.63 (0.16 – 2,46)
1.66 (0.40 – 6.88)
1.85 (0.53 – 6.38)
p value
0.427
0.759
0.718
0.516
Normal salivation
Table 1. Association of mucosal lesion, parotid hypertrophy and dental caries according to salivary flow.
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revealed that they brush their teeth twice and three
times a day. One third of the children had a bleed-
ings gum when they were brushing. Almost half
children (48%) related consume sugar between
the meals.
Discussion
Mozambique is one of the countries of the world
most affected by the HIV / AIDS, with an esti-
mated prevalence of 16.2%. Half of young popu-
lation, 99,000, are HIV-infected and only 8% of
these have access to antiretroviral therapy (ART)4.
In this study the use of ART was very usual prob-
ably due to the fact that the evaluated subjects
attending at pediatric DAY hospital. Institutions
like this are important for care and supervision
of HIV individuals, providing care, thereby in-
creasing the expectation and quality of life, in-
cluding contributing to oral health.
Low flow salivation were most often found
in these patients, as a side effect of antiviral med-
ications or of the other antihypertensive, antide-
pressant, anxiolytic or analgesic medications
commonly prescribed for patients with HIV in-
fection. Although was not found relation between
salivary flow and oral lesions (dental caries and
mucosal lesions), the oral dryness presents a sig-
nificant risk factor for caries and xerostomia also
contributes to oral candidiasis, mucosal injury
and dysphagia and is often associated with pain
and reduced oral intake of food15.
The secondly common oral HIV manifesta-
tion was parotid gland disease, characterized clin-
ically by gland enlargement. Parotid hypertro-
phy has been recognized as a distinct feature of
HIV infection in children since the disease was
first described. The parotid hypertrophy is a pre-
dictor of positive prognosis and long-term sur-
vival in HIV-infected children16.
In the developing world, the prevalence of
these lesions in children may vary from country
to country17. In a South African study, the data
showed higher prevalence with 63% of paediatric
outpatients having oral facial lesions associated
with HIV disease. Pseudomembranous candidi-
asis was the most commonly identified lesion,
followed by oral ulceration and then oral hairy
leukoplakia. In the same study, almost 50% of
children in non-hospital institutions had unilat-
eral parotid hypertrophy18. The prevalence of oral
Kaposi sarcoma and ranula were increasing in
HIV-infected children in Zimbabwe19. Several
studies have reported an increase in the number
of HIV-infected children with cancrum oris, cas-
es reported from Lesotho, South Africa and Zim-
babwe17-19.
In the United Republic of Tanzania oral can-
didiasis and oral hairy leukoplakia were strong
predictors for HIV infection. In the Democratic
Republic of the Congo, oral candidiasis was one
of several clinical features related to HIV sero-
conversion. In Nigeria 27% of cases were associ-
ated with advanced HIV infection. In Zambia
erythematous candidiasis was the only lesion sig-
nificantly associated with CD4+ lymphocyte less
than 200 cells/mm³ 15.
This present study illustrated two forms of
candidiasis, pseudomembraneous candidiasis
and angular chelitis. World workshop on HIV
and oral lesions concluded that oral candidiasis
is the most common lesion in children, but there
is a lack of data in poor countries. Noma is seen
Total
Mucosal Lesion
Presence
Absent
Parotid Gland
Hipertrophy
Normal
Dental caries
dmft=0
dmft>0
DMFT=0
DMFT>0
Without ART
n (%)
17 (18.8)
3 (17.6)
14 (82.4)
6 (35.3)
11 (64.7)
12 (70.6)
5 (29.4)
16 (94.1)
1 (5.9)
n (%)
73 (81.1)
6 (8.2)
67 (91.8)
15 (20.5)
58 (79.5)
18 (24.7)
55 (75.3)
55 (75.3)
18 (24.7)
OR (IC=95%)
2.39 (0.53 a 10.73)
2.11 (0.67 – 6.63)
7.33 (2.27 – 23.66)
5.24 (0.65 – 42.30)
p value
0.472
0.328
0.000
0.168
With ART
Table 2. Association of mucosal lesion, hypertrophy of parotid gland and dental caries according to use of
antiretroviral therapy (ART).
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in poor countries. Oral candidiasis, ulcerative
periodontal disease and xerostomia is strongly
associated with the progression of HIV disease20.
Therefore, the use of ART has showed a lower
frequence of oral manifestations in these patients.
In the study of Chidzonga21, the sample was
composed by 156 patients at age range from 1 to
56 years. Candidiasis (55.1%) was the most com-
mon lesion with the pseudomembranous type
(55.8%) predominating. High prevalence of Ka-
posi’s sarcoma (18.6%), salivary gland disease
(12.2%) and cancrum oris (3.8%) were noted21.
In South Africa an oral examination was per-
formed on 87 children ranged between 3.2 and 7,
who were not receiving antiretroviral treatment.
Rampant caries early in childhood was found in
19 (21.8%) children, with 5 children suffering se-
vere pain from multiple carious teeth. In the hos-
pice section of the homes all 12 children had clin-
ically detectable candidiasis, while in 4 (33.3%)
there was an associated bleeding and ulceration
of the oral mucosa, impairing their ability to eat22.
The study in Romani population consisted of
173 children at age range 6 to 12 years, the most
common oral and perioral lesions included: can-
didiasis (29%), ulcers (15%), salivary gland dis-
ease (9%), necrotizing ulcerative gingivitis/peri-
odontitis (5%), linear gingival erythema (4%),
labial molluscum contagiosum (3%), oral warts
(2%), hairy leukoplakia (2%), and herpes zoster
(1%). One or more oral/perioral lesions occurred
in 55% of the children. Severe dental caries was
noted in the majority of children (dmfs/dmft 16.9/
3.7 and DMFS/DMFT 8.1/3.1)23.
This survey revealed the prevalence of dental
caries was high in primary dentition. In 1991, Ge-
hrke and Johnsen24 reported the first case of the
bottle caries associated with ART, where a child of
two years was associated with use of Retrovir
bottle at night and bad oral hygiene. According to
Howell et al.25 the prevalence of caries in HIV chil-
dren was very high, especially with deciduous den-
tition. Tofsky et al.26 found a mean dmft average
of 8.3 for children with HIV, while for children
not infected with HIV this average was 3.1 teeth,
which shows, according to the authors, the need
of guidance and treatment for those infected pa-
tients. A comparative study of the prevalence of
caries, by Souza et al.10 in HIV infected children
and children without evidence of immunosup-
pression, showed statistically significant difference
between the average mean dmft (5.29; 2.59) and
DMFT (2.36; 0.74) of the two groups, respective-
ly. Other recent studies showed that the high prev-
alence of caries in infected children seems to be
greater in those that are in advanced stage of dis-
ease and with more severe degree of immunosup-
pression27. Studies have attributed the relation-
ship between the presence of dental caries with the
use of ART in syrup form with sugar24, which
may partly explain the higher prevalence dental
caries in deciduous teeth of individuals in this
study. In addition, the diet habits reported in
present study showed that there was increase of
sugar consumption between meals.
The exploratory questions showed that the
almost children use dentifrice with fluoride, for
3-times a day or more (55.6%). However, these
results should be carefully analyzed due the high
prevalence of dental caries in these patients.
It is important to integrate oral health research
into other health care research programmers as
well as the caregivers because the control of dental
caries contingent on the positive influence of the
mother or the guardian, who must supervise the
oral hygiene. The caregiver influences the child with
their perceptions, values and estimates, which
should be considered in care.  Oral health care
providers should familiarize in detection, recog-
nition and management of these signs and symp-
toms of HIV/AIDS in neck and head regions.
Conclusion
There is a need to update and revise the classifi-
cation criteria for diagnosis of oral manifesta-
tions in children with HIV infection to include
data from Africa. It would seem that patients who
make use of ART have high prevalence of caries
and less likely to have lesions in the oral mucosa.
There is a need to centralize research efforts
in poor countries to support standardized stud-
ies in order to explore the use of oral lesions as
surrogate markers for the initiation of antiretro-
viral therapy and prophylaxis of opportunistic
diseases.
Contributors
SHC Sales-Peres, MAA Mapengo, PG Moura-
Grec, JA Marsicano, AC Sales-Peres and A Sales-
Peres participated in the article conception, data
analysis and interpretation, article write-up, crit-
ical revision and approval of the final version for
publication.
6 0
S
al
es
-P
er
es
 S
H
C
 e
t 
a
l.
Acknowledgments
Special thanks to the children and caregivers those
attending the DAY’s Maputo Central Hospital to
Hodgson TA, Naidoo S, Chidzonga M, Ramos Go-
mez F, Shiboski C. Identification of oral health care
needs in children and adults, management of oral
diseases. Adv Dent Res 2006; 19(1):106-117.
Rath IBS. Evaluation of pH and salivary flow in HIV-
infected children and their relationship to disease of
the salivary glands associated with HIV and the rate of
dental caries [master’s thesis]. Florianópolis: Feder-
al University of Santa Catarina; 2006.
Coogan MM, Greenspan J, Challacombe SJ. Oral
lesion in infection with immunodeficiency  virus.
Bull World Health Org 2005; 83(9):700-706.
Naidoo S, Chikte U. Oro-facial manifestations in
paediatric HIV: a comparative study of institution-
alized and hospital outpatients. Oral Dis 2004;
10(1):13-18.
Chidzonga MM. Noma (cancrum oris) in human
immunodeficiency virus/ acquired immune defi-
ciency syndrome patients: report of eight cases. J
Oral Max Surg 1996; 54(9):1056-1060.
Ashir GM, Gofana MM, Rabas AI, Bashir I, Halima
IU. Related oral candidiasis in Nigerian children: a
marker of HIV disease progression. SAJCH 2008;
2(4):152-154.
Chidzonga MM. HIV/AIDS orofacial lesions in 156
Zimbabwean patients at referral oral and maxillo-
facial surgical clinics. Oral Dis 2003; 9(6):317–322.
Blignaut E. Oral health needs of HIV/AIDS orphans
in Gauteng, South Africa. AIDS Care 2007; 19(4):532-
538.
Flaitz C, Wullbrandt B, Sexton J, Bourdon T, Hicks
J. Prevalence of orodental findings in HIV-infected
Romanian children. Pediatr Dent 2001; 23(1):44-50.
Gehrke FS, Johnsen DS. Bottle caries associated
with anti-HIV therapy. Pediatr Dent 1991;13(1):73.
Howell RB, Jandinski J, Palumbo P, Shey Z, Houpt
M. Dental caries in Hiv-infected children. Pediatr
Dent 1992;14(6):370-371.
Tofsky N, Schoen D, Jandinski J, et al. Dental caries
in children with Aids. J Dent Res 1995; 74:191.
Castro GF, Souza IP, Chianca TK, Hugo R. Evalua-
tion of caries prevention program in HIV+ chil-
dren. Braz Oral Res 1997; 15(2):91-97.
Artigo apresentado em 08/04/2010
Aprovado em 15/06/2010
Versão final apresentada em 05/07/2010
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
References
Joint United Nations Programme on HIV/AIDS (UN-
AIDS). AIDS epidemic update. Special report on HIV/
AIDS. Geneva: Joint United Nations Programme on
HIV/AIDS (UNAIDS), World Health Organization
(WHO); 2006. [cited 2009 Aug 31]. Available from:
http://data.unaids.org/pub/EpiReport/2006/2006_
EpiUpdate_en.pdf
Ramos-Gomez FJ, Hilton JF, Canchola AJ,
Greenspan D, Greenspan JS, Maldonato YA.  Risk
factors for Hiv-related orofacial soft-tissue manifes-
tations in children. Pediat Dent 1996; 18(2):121-126.
Ribeiro A, Portela M, Souza IP. Relation between
biofilm, caries activity and gingivitis in HIV+ chil-
dren. Braz Oral Res 2002; 16(2):144-150.
The United Nations Children’s Fund (UNICEF).
HIV-AIDS. Unicef Mozambique [Internet]. [updat-
ed 2008 Apr 28; cited 2009 Aug 31]. Available from:
http://www.unicef.org/mozambique/.
Greenspan JS, Greenspan D. The epidemiology of
the oral lesions of HIV infection in the developed
world. Oral Dis 2002; 8(Suppl. 2):34-39.
Hodgson TA, Greenspan D, Greenspan JS. Oral le-
sions of HIV disease in industrialized countries.
Adv Dent Res 2006; 19(1):57-62.
Phelan JA, Begg MD, Lamster IB, Gorman J, Mitch-
ell-Lewis D, Bucklan RD, El-Sadr WM. Oral candid-
iasis in HIV infection: predictive value and compar-
ison of findings in injecting drug users and homo-
sexual men. J Oral Pathol Med 1997; 26(5):237-243.
Mcgrath C, Broder H, Wilson-Genderson M. As-
sessing the impact of oral health on the quality of
children: Implications for research and Practice.
Community Dent Oral Epidemiol 2004; 32(2):81-85.
Ribeiro AA, Bunzman ER, Nishio C, Souza IPR.
Relation between salivary flow, medicines and car-
ies in HIV+ children. J Dent Res 1998; 77:841.
Souza IPR, Teles GS, Castro GF, Guimarães L, Vi-
ana RBC, Peres M. Prevalence of dental caries in
HIV-infected children. Rev Bras Odontol 1996;
53(1):49-51.
Landis JR, Koch GG. An application of hierarchical
kappa-type statistics in the assessment of majority
agreement among multiple observers. Biometrics
1977; 33(2):363-374.
World Health Organization (WHO). Oral health
surveys: basic methods. 4th Edition. Geneva: World
Health Organization (WHO); 1997.
Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P,
Milnes AR, Dorenbaum A. Classification, diagnos-
tic criteria and treatment recommendations for oro-
facial manifestations in HIV-infected pediatric pa-
tients. J Clin Pediatr Dent 1999; 23(2):85-96.
Navarro MF, Cortes DF. Assessment and treatment
of patients with the risk of caries. Maxiodonto dentís-
tica 1995; 1(4):1-38.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
participate in research. Also thank Fabiano Vil-
hena from Oralls, whose offered brushes, door
brush and dentifrice for these children living with
HIV virus.
